Monitoring levels of DNA in the blood could indicate treatment response

Monitoring levels of DNA in the blood could indicate treatment response

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

 READ HERE
SEE ALL NEWS
Recent Posts
5 Healthy Habits That Help During Cancer Treatment Understanding Mammogram Results A 19-Year Fight Against Prostate Cancer Brings Man to Johns Hopkins Medicine Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells Ultra-Processed Foods: Q&A with 2 Dietitians Radiation Therapy Overcomes Immunotherapy Resistance in Some Cancers ‘Power Surges’ on Cancer Cell Membranes May Fuel Progression of Disease New Cancer Target Discovered How surgeons build a new bladder for cancer patients like Deion Sanders